# CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: 02182135
- Contract winner: Roche Products Ltd
- Award value: £46,600,000
- Tender value: £46,600,000
- Award date: 11 March 2024
- Published: 8 April 2024
- Contract start: 1 March 2024
- Contract end: 28 February 2025
- Stage: awarded
- Procurement category: goods
- Notice ID: 740537ba-c484-46a9-82ca-abe7901d188e-738925
- OCID: ocds-b5fd17-57b54e85-da9c-4332-bb93-8a7359735da5

## Description

Project Title: NHS National Framework for Tocilizumab - March 2024 Offer reference number: CM/PHR/23/5702 CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND\. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\. CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST\. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\.

## Related contract awards

- [NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National](/contracts/ocds-b5fd17-5ea01c9a-8442-488c-bb4a-cdfa18d54a6c): NHS England
- [NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche](/contracts/ocds-b5fd17-9ad5373a-6289-47c2-89c6-8c7250be3555): NHS England
- [REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSES](/contracts/ocds-b5fd17-808eefe6-4110-42b8-8b0d-4a49deb28d40): Business Energy and Industrial Strategy

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/740537ba-c484-46a9-82ca-abe7901d188e-738925)